Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

111 ta ish

Ish: The microbiome and precision oncology: an emerging paradigm in anticancer therapy

  1. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67

    Maqola20177 iqtibos
    ABI

  2. The Human Microbiome Project

    Peter J. Turnbaugh, Ruth E. Ley, Micah Hamady +3

    MaqolaOchiq kirish20076 iqtibos
    ABI

  3. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

    Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa +45

    Maqola20175 iqtibos
    ABI

  4. Roles of the immune system in cancer: from tumor initiation to metastatic progression

    Hugo González, Catharina Hagerling, Zena Werb

    Sharh maqolaOchiq kirish20184 iqtibos
    ABI

  5. One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering

    Haoyi Wang, Hui Yang, Chikdu Shivalila +4

    MaqolaOchiq kirish20134 iqtibos
    ABI

  6. Human papillomavirus and cervical cancer

    Mark Schiffman, Philip E. Castle, José Jerónimo +2

    Sharh maqola20074 iqtibos
    ABI

  7. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

    Marie Vétizou, Jonathan M. Pitt, Romain Daillère +35

    Maqola20154 iqtibos
    ABI

  8. Commensal <i>Bifidobacterium</i> promotes antitumor immunity and facilitates anti–PD-L1 efficacy

    Ayelet Sivan, Leticia Corrales, Nathaniel Hubert +9

    Maqola20154 iqtibos
    ABI

  9. The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients

    Vyara Matson, Jessica Fessler, Riyue Bao +5

    Maqola20184 iqtibos
    ABI

  10. The human tumor microbiome is composed of tumor type–specific intracellular bacteria

    Deborah Nejman, Ilana Livyatan, Garold Fuks +58

    Maqola20204 iqtibos
    ABI

  11. Anticancer effects of the microbiome and its products

    Laurence Zitvogel, Romain Daillère, María Paula Roberti +2

    Sharh maqola20173 iqtibos
    ABI

  12. Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans

    Ron Sender, Shai Fuchs, Ron Milo

    Maqola20163 iqtibos
    ABI

  13. Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme

    Bret D. Wallace, Hongwei Wang, Kimberly T. Lane +8

    Maqola20103 iqtibos
    ABI

  14. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

    Romain Daillère, Marie Vétizou, Nadine Waldschmitt +33

    Maqola20163 iqtibos
    ABI

  15. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

    Leore T. Geller, Michal Barzily-Rokni, Tal Danino +44

    Maqola20173 iqtibos
    ABI

  16. Cancer statistics, 2020

    Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal

    Maqola20203 iqtibos
    ABI

  17. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

    Sandra Demaria, Bruce Ng, M. Devitt +4

    Maqola20042 iqtibos
    ABI

  18. The future of immune checkpoint therapy

    Padmanee Sharma, James P. Allison

    Sharh maqola20152 iqtibos
    ABI

  19. Gut biogeography of the bacterial microbiota

    Gregory P. Donaldson, S. Melanie Lee, Sarkis K. Mazmanian

    Sharh maqolaOchiq kirish20152 iqtibos
    ABI

  20. Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

    Leonard B. Saltz, John V. Cox, Charles D. Blanke +9

    MaqolaOchiq kirish20002 iqtibos
    ABI

  21. Doxorubicin: The Good, the Bad and the Ugly Effect

    Cristina Carvalho, Renato X. Santos, Susana Cardoso +4

    Sharh maqola20092 iqtibos
    ABI

  22. The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

    Sophie Viaud, Fabiana Saccheri, Grégoire Mignot +30

    Maqola20132 iqtibos
    ABI

  23. Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

    Sunil Verma, David Miles, Luca Gianni +11

    Maqola20122 iqtibos
    ABI

  24. Tumor-Associated Microbiome: Where Do We Stand?

    Marc Oliva, Núria Mulet-Margalef, María Ochoa-de-Olza +7

    Sharh maqola20212 iqtibos
    ABI

  25. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity

    Yao He, Liuhui Fu, Yiping Li +10

    Maqola20212 iqtibos
    ABI